MYSE secures Israel Patent Office grant: patent no. 290546

Rhea-AI Filing Summary

Myseum, Inc. (MYSE) reported a new patent grant in Israel. The company announced that the Israel Patent Office has granted patent no. 290546 for its invention titled “Systems and Methods of Transforming Electronic Content.” The disclosure was made via an 8-K under “Other Events,” with a press release furnished as Exhibit 99.1.

The filing highlights intellectual property progress tied to Myseum’s content transformation technology. The company’s common stock trades on Nasdaq under MYSE; Series A Warrants trade as MYSEW.

Insights

Intellectual Property Strategist

Israel patent grant strengthens Myseum’s IP footprint for content tech.

Myseum received an Israel Patent Office grant for patent no. 290546 covering “Systems and Methods of Transforming Electronic Content.” An issued patent can provide exclusivity in that jurisdiction, which may support product protection or partnerships that rely on defensible IP.

The filing lists this as an “Other Events” update with a press release attached (Exhibit 99.1). While commercial terms are not included, a granted patent typically enhances legal protection around the described methods. Actual business impact depends on how closely Myseum’s offerings align with the granted claims.

false 0001648960 0001648960 2025-10-13 2025-10-13 0001648960 MYSE:CommonStock0.0001ParValueMember 2025-10-13 2025-10-13 0001648960 MYSE:SeriesWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf49.80Member 2025-10-13 2025-10-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 13, 2025

MYSEUM, INC.

(Exact name of registrant as specified in its charter)

Nevada		001-40729		47-2502264
(State or other jurisdiction of incorporation)		(Commission File Number)		(I. R. S. Employer Identification No.)

65 Church Street, Suite 230

New Brunswick, NJ 08901

(Address of principal executive offices, including ZIP code)

(732) 374-3529

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbol(s)		Name of each exchange on which registered:
Common Stock, $0.0001 par value		MYSE		The Nasdaq Stock Market LLC
Series A Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $49.80		MYSEW		The Nasdaq Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On October 13, 2025, Myseum, Inc. (the “Company”) issued a press release announcing that the Israel Patent Office has granted patent no. 290546 for the Company’s invention titled “Systems and Methods of Transforming Electronic Content." A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.

Exhibit No.		Description of Exhibit
99.1		Press release dated October 13, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 14, 2025	MYSEUM, INC.
	/s/ Darin Myman
	Darin Myman
	Chief Executive Officer

2

FAQ

What did MYSE announce in its 8-K?

Myseum reported that the Israel Patent Office granted patent no. 290546 titled “Systems and Methods of Transforming Electronic Content,” with details in Exhibit 99.1.

When was Myseum’s patent grant announced?

The company announced the grant on October 13, 2025.

Which patent office granted MYSE’s patent and what is the number?

The Israel Patent Office granted patent no. 290546.

What is the title of the newly granted MYSE patent?

“Systems and Methods of Transforming Electronic Content.”

Where can I find more details in the filing?

See Exhibit 99.1 (press release) referenced in Item 8.01 of the 8-K.

What are MYSE’s trading symbols?

Common Stock trades as MYSE; Series A Warrants trade as MYSEW on Nasdaq.